201 related articles for article (PubMed ID: 29517696)
21. Interleukin 28A.rs12980602 and interleukin 28B.rs8103142 genotypes could be protective against HCV infection among Egyptians.
Zakaria ZA; Knapp S; Hashem M; Zaghla H; Thursz M; Waked I; Abdelwahab S
Immunol Res; 2019 Feb; 67(1):123-133. PubMed ID: 30402710
[TBL] [Abstract][Full Text] [Related]
22. IL-28B predicts response to chronic hepatitis C therapy--fine-mapping and replication study in Asian populations.
Ochi H; Maekawa T; Abe H; Hayashida Y; Nakano R; Imamura M; Hiraga N; Kawakami Y; Aimitsu S; Kao JH; Kubo M; Tsunoda T; Kumada H; Nakamura Y; Hayes CN; Chayama K
J Gen Virol; 2011 May; 92(Pt 5):1071-1081. PubMed ID: 21228123
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis.
Derbala M; Rizk N; Shebl F; Alkaabi S; Eldweik N; John A; Sharma M; Yaqoob R; Almohanadi M; Butt M; Alejji K
World J Gastroenterol; 2012 Dec; 18(47):7003-8. PubMed ID: 23323000
[TBL] [Abstract][Full Text] [Related]
24. Study of Interleukin 28B rs12979860 and rs8099917 Polymorphisms and T-helper 1 Response in Hepatitis C Virus Patients.
Ea R; Aa G; Ag ES; Ma A
Egypt J Immunol; 2015 Jun; 22(2):57-68. PubMed ID: 28502145
[TBL] [Abstract][Full Text] [Related]
25. Extracellular Matrix Proteins Substantiate IL-28B T allele Effect on Histological Outcome of Chronic Hepatitis C.
Attallah AM; Omran D; Omran MM; Abdelrazek MA; Zayed R; Essawey RE; Saif S; Farid A; Hassany M; Yosry A; Omar A
Ann Hepatol; 2018 July - August ,; 17(4):569-576. PubMed ID: 29893697
[TBL] [Abstract][Full Text] [Related]
26. Interleukin 28B-related polymorphisms: a pathway for understanding hepatitis C virus infection?
Garcia RF; Moreira S; de Araújo Ramos AL; Ferreira LE; de Mattos AA; Tovo CV; Nader LA; Ramos JA; Rondinelli E; de Jesus Dominici A; Garcia CE; de Souza Leite Pinho M; Brandão-Mello CE; Villela-Nogueira CA; de França PH
World J Gastroenterol; 2013 Nov; 19(42):7399-404. PubMed ID: 24259970
[TBL] [Abstract][Full Text] [Related]
27. High hepatitis B virus surface antigen levels and favorable interleukin 28B genotype predict spontaneous hepatitis C virus clearance in uremic patients.
Yu ML; Dai CY; Huang CF; Lee JJ; Yeh ML; Yeh SM; Kuo HT; Huang JF; Chang JM; Chen HC; Juo SH; Hwang SJ; Chuang WL;
J Hepatol; 2014 Feb; 60(2):253-9. PubMed ID: 24096049
[TBL] [Abstract][Full Text] [Related]
28. Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.
Barreiro P; Pineda JA; Rallón N; Naggie S; Martín-Carbonero L; Neukam K; Rivero A; Benito JM; Caruz A; Vispo E; Camacho A; Medrano J; McHutchison J; Soriano V
J Infect Dis; 2011 Jun; 203(11):1629-36. PubMed ID: 21592993
[TBL] [Abstract][Full Text] [Related]
29. Association of interleukin 28B and mutations in the core and NS5A region of hepatitis C virus with response to peg-interferon and ribavirin therapy.
Hayashi K; Katano Y; Honda T; Ishigami M; Itoh A; Hirooka Y; Ishikawa T; Nakano I; Yoshioka K; Toyoda H; Kumada T; Goto H
Liver Int; 2011 Oct; 31(9):1359-65. PubMed ID: 21745312
[TBL] [Abstract][Full Text] [Related]
30. Polymorphism in interferon λ3/interleukin-28B gene and risk to noncirrhotic chronic hepatitis C genotype 3 virus infection and its effect on the response to combined daclatasvir and sofosbuvir therapy.
Khan AJ; Saraswat VA; Ranjan P; Parmar D; Negi TS; Mohindra S
J Med Virol; 2019 Apr; 91(4):659-667. PubMed ID: 30431653
[TBL] [Abstract][Full Text] [Related]
31. Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype.
Huang CF; Yu ML; Kao JH; Tseng TC; Yeh ML; Huang JF; Dai CY; Lin ZY; Chen SC; Wang LY; Juo SH; Chuang WL; Liu CH
J Clin Virol; 2013 Apr; 56(4):293-8. PubMed ID: 23246359
[TBL] [Abstract][Full Text] [Related]
32. Evolution of fibrosis during HCV recurrence after liver transplantation--influence of IL-28B SNP and response to peg-IFN and ribavirin treatment.
Ackefors M; Nyström J; Wernerson A; Gjertsen H; Sönnerborg A; Weiland O
J Viral Hepat; 2013 Nov; 20(11):770-8. PubMed ID: 24168256
[TBL] [Abstract][Full Text] [Related]
33. Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.
Hsu CS; Liu CH; Liu CJ; Hsu SJ; Chen CL; Hwang JJ; Lai MY; Chen PJ; Chen DS; Kao JH
J Gastroenterol Hepatol; 2010 May; 25(5):970-7. PubMed ID: 20546452
[TBL] [Abstract][Full Text] [Related]
34. Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy.
Liu CH; Liang CC; Liu CJ; Tseng TC; Lin CL; Yang SS; Su TH; Hsu SJ; Lin JW; Chen JH; Chen PJ; Chen DS; Kao JH
Antivir Ther; 2012; 17(3):477-84. PubMed ID: 22301466
[TBL] [Abstract][Full Text] [Related]
35. Genetic variation in interleukin 28B and response to antiviral therapy in patients with dual chronic infection with hepatitis B and C viruses.
Guo X; Yang G; Yuan J; Ruan P; Zhang M; Chen X; Zhou B
PLoS One; 2013; 8(10):e77911. PubMed ID: 24147097
[TBL] [Abstract][Full Text] [Related]
36. [PROGNOSTIC VALUE OF THE COMBINATION OF BLOOD GROUP SPECIFICITY AND INTERLEUKIN 28B GENE POLYMORPHISM FOR ESTIMATION OF EFFICIENCY OF THERAPY WITH THE USE OF PEGYLATED INTERFERON α-2 AND RIBAVARIN IN PATIENTS WITH CHRONIC GENOTYPE 1 HEPATITIS C].
Ogurtsov PP; Kukhareva EI
Klin Med (Mosk); 2016; 94(3):224-30. PubMed ID: 27522730
[TBL] [Abstract][Full Text] [Related]
37. High frequencies of a favorable IL-28B rs8099917 polymorphism and the clinical implications in patients with HCV in one multiracial area of Taiwan.
Cheng CH; Lin CC; Chen HL; Lin IT; Wu CH; Lee YK; Wong MW; Bair MJ
Kaohsiung J Med Sci; 2017 Oct; 33(10):510-515. PubMed ID: 28962822
[TBL] [Abstract][Full Text] [Related]
38. IL-28B genetic variation, gender, age, jaundice, hepatitis C virus genotype, and hepatitis B virus and HIV co-infection in spontaneous clearance of hepatitis C virus.
Fedorchenko SV; Klimenko A; Martynovich T; Liashok O; Yanchenko V
Turk J Gastroenterol; 2019 May; 30(5):436-444. PubMed ID: 31060998
[TBL] [Abstract][Full Text] [Related]
39. Role of interleukin 28B-related gene polymorphisms in chronic hepatitis C and the response to antiviral therapy in Koreans.
Jung YK; Kim JH; Ahn SM; Yang JW; Park SJ; Kim JW; Yeon JE; Kwon OS; Kim YS; Choi DJ; Kim JH; Byun KS
J Clin Gastroenterol; 2013 Aug; 47(7):644-50. PubMed ID: 23442843
[TBL] [Abstract][Full Text] [Related]
40. Genetic polymorphisms of ICAM 1 and IL28 as predictors of liver fibrosis severity and viral clearance in hepatitis C genotype 4.
Rizk NM; Derbala MF
Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):262-8. PubMed ID: 23137758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
